Opinion

In re Novartis and Par Antitrust Litigation

Court
District Court, S.D. New York
Filed
Mar 3, 2022
Cited by
0 cases
Authority
More cited than 27.4%

finding it appropriate for materials to remain under seal

How later courts described this case

  • finding it appropriate for materials to remain under seal

Written by the judges who cited it.

The opinion

so ordered.

/s/ Alvin K. Hellerstein

March 3, 2022

LAW OFFICES

WILLIAMS &® CONNOLLY LLP

725 TWELFTH STREET, N.W.

CHET OTIS WASHINGTON, D. C. 20005-5901 SSWARD SENET WILLIAMS □□□□□□□□□□

O08) BESS (202) 434-5000 ON”

rcotis@we.com

FAX (202) 434-5029

February 28, 2022

Re: Inre Novartis and Par Antitrust Litigation, 1:18-cv-04361-AKH

Dear Judge Hellerstein:

Pursuant to Rules 4.A and 4.B.11 of Your Honor’s Individual Rules of Practice, Paragraph

19 of the Amended Stipulated Protective Order (the “Protective Order”) (ECF Nos. 95, 415) and

applicable law, I write on behalf of Par Pharmaceutical, Inc. (“Par”) requesting permission to file

certain documents under seal in connection with Plaintiffs’ Motion to Compel Production of

Documents (ECF Nos. 433, 434, 437, 439). Par has conferred with Plaintiffs regarding this

motion. DPPs and EPPs take no position on the motion but reserve the right to file a response to

this letter motion; Retailer Plaintiffs do not oppose Par’s proposed redactions.

Under Rule 4.A of Your Honor’s Individual Rules of Practice, a party must obtain the

Court’s authority to file documents under seal, which is appropriate if “closure is essential to

preserve higher values and is narrowly tailored to serve that interest.” Bernstein v. Bernstein

Litowitz Berger & Grossmann LLP, 814 F.3d 132, 144 (2d Cir. 2016) (quoting In re N.Y. Times

Co., 828 F.2d 110, 116 (2d Cir.1987)). While there is a “common law presumption in favor of

permitting public access to judicial documents,” the court must consider the “the privacy

interests of those resisting disclosure.” Lugosch v. Pyramid Co. of Onondaga, 435 F.3d 110 □□

Cir. 2006). Courts have recognized that “notwithstanding the presumption of public access to

judicial records, courts may deny access to records that are sources of business information that

might harm a litigant's competitive standing.” In re Parmalat Sec. Litig., 258 F.R.D. 236, 244

(S.D.N.Y. 2009) (quoting Nixon v. Warner Commc'ns, Inc., 435 U.S. 589, 598, 98 S. Ct. 1306,

1312, 55 L. Ed. 2d 570 (1978)). For example, when documents “contain highly proprietary

material concerning the defendants’ marketing strategies, product development, costs and

budgeting, [] the privacy interests of the defendants outweigh the presumption of public access.”

GoSMILE, Inc. v. Dr. Jonathan Levine, D.M.D. P.C., 769 F. Supp. 2d 630, 649-50 (S.D.N.Y.

2011) (finding it appropriate for materials to remain under seal); see also United States v.

Ferguson, No. CRIM. 3:06CR137CFD, 2008 WL 113654, at *1 (D. Conn. Jan. 5, 2008)

(granting motion to seal confidential business information “because the disclosure of this

confidential information would cause undue harm to the businesses involved’’). Moreover,

where a public filing would reveal a party’s privileged information, it must also remain under

seal. See Utica Mutual Ins. Co. v. INA Reinsurance Co., No. 12-CV-194, 2012 WL 13028279, at

*8 (N.D.N.Y June 12, 2012).

WILLIAMS 8 CONNOLLY LLP

February 28, 2022

Page 2

Plaintiffs’ Memorandum in Support of Plaintiffs’ Motion to Compel Production of

Documents, ECF No. 433 (“Plaintiffs’ Motion’), contains discussions of a Par document

reflecting Par’s privileged information. Those discussions reveal the contents of Par’s privileged

information. As such, Par respectfully submits that Plaintiffs’ Motion should remain sealed in

part. Par has provided Plaintiffs its proposed redactions to Plaintiffs’ Motion. Par’s redactions

are limited to those necessary to protect Par’s privileged information.

Exhibit 1, ECF No. 434-1, to the Declaration of Deborah A. Elman, ECF No. 434,

includes confidential information concerning Par’s portfolio of potential new product launches;

the document relates almost exclusively to products other than generic Exforge. Much of this

information is forward-looking and sensitive, disclosure of which would harm Par’s competitive

standing. Because individualized redaction of that information is impractical, Par respectfully

submits that this document should remain sealed in its entirety.

Defendants’ Memorandum of Law in Opposition to Plaintiffs’ Motion to Compel

Production of Documents, ECF No. 437 (“Defendants’ Opposition”), contains discussions of a

Par document reflecting Par’s privileged information. Those discussions reveal the contents of

Par’s privileged information. As such, Par respectfully submits that Defendants’ Opposition

should remain sealed in part. Novartis has filed a copy of Defendants’ Opposition reflecting

Par’s proposed redactions contemporaneous with the filing of this motion (see ECF No. 457).

Par’s redactions are highlighted in green in the highlighted version. Par’s redactions are limited

to those necessary to protect Par’s privileged information.

Plaintiffs’ Reply Memorandum of Law in Further Support of Plaintiffs’ Motion to

Compel Production of Documents, ECF No. 439 (“Plaintiffs’ Reply”), contains discussions of a

Par document reflecting Par’s privileged information. Those discussions reveal the contents of

Par’s privileged information. As such, Par respectfully submits that Plaintiffs’ Reply should

remain sealed in part. Par has provided Plaintiffs its proposed redactions to Plaintiffs’ Reply.

Par’s redactions are limited to those necessary to protect Par’s privileged information.

Par is available at the Court’s convenience should Your Honor have any questions or

wish to discuss these requests.

Sincerely,

/s/ R. Chet Otis

The Honorable Alvin K. Hellerstein

United States District Court

Southern District of New York

500 Pearl Street, Room 1050

New York, New York 10007

WILLIAMS 8 CONNOLLY LLP

February 28, 2022

Page 3

BY ECF

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.